The bladder cancer-associated transcript 2 (BLACAT2), also known as LINC00958, was initially identified by Seitz et al. [101] as a candidate oncogene in bladder cancer and is regarded as one of the first examples of an lncRNA promoting VEGF-C-induced tumor lymphangiogenesis and lymphatic metastasis. Here, LINC00958 is linked to urinary bladder carcinoma.